Viewing Study NCT02733094


Ignite Creation Date: 2025-12-25 @ 2:00 AM
Ignite Modification Date: 2026-03-03 @ 3:54 PM
Study NCT ID: NCT02733094
Status: COMPLETED
Last Update Posted: 2023-04-12
First Post: 2016-03-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Single-arm Study to Assess a Potential Effect of Anti-IL-17 (Secukinumab) in the Treatment of Pyoderma Gangrenosum
Sponsor: Technical University of Munich
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pyoderma Gangrenosum View
Keywords: